• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 4, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Historic growth in impact factors for Mary Ann Liebert, Inc. journals

Bioengineer by Bioengineer
June 26, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

New Rochelle, NY, June 26, 2018– Mary Ann Liebert, Inc., publishers announces significant growth in the impact factors of its peer-reviewed journals, as reported in the new Journal Citation Reports (Clarivate Analytics, 2018). More than 50% of the company's portfolio of previously indexed journals saw double-digit percentage increases in impact factors, including Thyroid with a 37% increase and new impact factor of 7.557; AIDS Patient Care and STDs , with a 25% increase and new impact factor of 4.041; LGBT Health , with a 22% increase and new impact factor of 2.514, and a first impact factor of 5.2 for Advances in Wound Care . The journal portfolio now boasts the highest average impact factor in the history of the company.

"We are pleased to see such excellent progress in the impact factors of our journals this year," says Vicki Cohn, Chief Editorial Officer of Mary Ann Liebert, Inc. "It is a tribute to the achievements and contributions of our authors, editors, editorial boards, and reviewers, and an indication of our publications' continued significance to the scientific community."

Flagship publications Human Gene Therapy and Tissue Engineering also saw growth in their impact factors and reinforced their positions as leaders in their respective fields. Human Gene Therapy Methods saw an impressive increase of 23%.

Also of note, critical new and established titles Journal of Adolescent and Young Adult Oncology, Surgical Infections, Astrobiology, Big Data, and DNA and Cell Biology saw increases of 51%, 48%, 39%, 20%, and 18%, respectively.

###

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company universally acknowledged for publishing authoritative peer-reviewed journals in the most promising areas of biomedical research, biotechnology and regenerative medicine, clinical medicine, public health, law, environmental studies, and technology and engineering. The company's publications make critical contributions in advancing research and facilitating collaboration throughout the world in academia, industry, and government, and are also highly respected resources for legislators, policymakers, and educators. A complete list of the firm's journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Media Contact

Kathryn Ryan
[email protected]
914-740-2250
@LiebertPub

http://www.liebertpub.com

https://home.liebertpub.com/news/historic-growth-in-impact-factors-for-mary-ann-liebert-inc-journals/2397

Share12Tweet8Share2ShareShareShare2

Related Posts

Parkinson’s Freezing of Gait Linked to State-Dependent Basal Forebrain-Cortical Gradient Failure

August 4, 2026

UI Health Ophthalmology Program Named Among Nation’s Best by U.S. News

August 4, 2026

Second Annual Booster Dose of VLA15 Lyme Vaccine Studied in Healthy Individuals

August 4, 2026

Japan’s Kawasaki Disease Epidemiology After the COVID-19 Pandemic, 2023–2024

August 4, 2026
Please login to join discussion

POPULAR NEWS

  • Parkinson’s Freezing of Gait Linked to State-Dependent Basal Forebrain-Cortical Gradient Failure

    29 shares
    Share 12 Tweet 7
  • New intelligence tracks solid-state batteries across their entire life cycle

    29 shares
    Share 12 Tweet 7
  • AKR1B10 Serum Marker Aids Liver Cancer Diagnosis and Postoperative Monitoring

    29 shares
    Share 12 Tweet 7
  • How Cytokine Signals from the Immune System Disrupt Brain Circuits

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Parkinson’s Freezing of Gait Linked to State-Dependent Basal Forebrain-Cortical Gradient Failure

New intelligence tracks solid-state batteries across their entire life cycle

AKR1B10 Serum Marker Aids Liver Cancer Diagnosis and Postoperative Monitoring

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.